Welcome to hiintermediates.com,intermediates trading platform
Home > products > Norglaucine

Norglaucine cas no:21848-62-4

Synonyms: (+)-N-Norglaucine;(6aS)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-4H-dibenzo[de,g]quinoline;[6aS,(+)]-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-4H-dibenzo[de,g]quinoline;d-N-Norglaucine;Norglaucin;Norglaucine

Identification
NameNorglaucine
CAS21848-62-4
Synonyms(+)-N-Norglaucine;(6aS)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-4H-dibenzo[de,g]quinoline;[6aS,(+)]-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-4H-dibenzo[de,g]quinoline;d-N-Norglaucine;Norglaucin;Norglaucine
Molecular FormulaC20H23NO4
Molecular Weight0
Chemical Properties
refractive index1.575
Safety Data

Safety

Poison by intravenous and intraperitoneal routes. Norglaucine (CAS NO.21848-62-4) is moderately toxic by ingestion. When Norglaucine (CAS NO.21848-62-4) is heated to decomposition ,it emits toxic fumes of NOx.


Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 170mg/kg (170mg/kg) CARDIAC: CHANGE IN RATE

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Annales Pharmaceutiques Francaises. Vol. 38, Pg. 537, 1980.
mouse LD50 intravenous 90mg/kg (90mg/kg) CARDIAC: CHANGE IN RATE

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Annales Pharmaceutiques Francaises. Vol. 38, Pg. 537, 1980.
mouse LD50 oral 450mg/kg (450mg/kg) CARDIAC: CHANGE IN RATE

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Annales Pharmaceutiques Francaises. Vol. 38, Pg. 537, 1980.

supplier list

Valeant international. inc
Tel:674-635-986524
Address: Anabar

Home   |   About Us   |   Service   |   Links   |   Add to  Favorite

Copyright©2011 HiIntermediates ICP: B2-20090288 浙ICP备09045134号-49
Tel: +86-0571-89739792